Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Patrick Schlievert

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Concepts & Ideas

Genes & Molecular Sequences

Amino Acid Sequence

Physiology

Lymphocyte Activation

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
21
Ohlendorf, Douglas
20
Bohach, Gregory
19
McCormick, John
15
Leung, Donald
13
Earhart, Cathleen
11
Tripp, Timothy
11
novick, Richard
9
Mariuzza, Roy
9
Peterson, Marnie
7
Dinges, Martin
7
Karjalainen, Klaus
7
Vath, GM
7
Yarwood, Jeremy
6
Stoehr, JA
6
Kreiswirth, Barry

Sign-in to see all Coauthors

Publications

TOP 3
Strandberg Kristi L; Peterson Marnie L; Schaefers Matthew M; Case Laura C; Pack Melinda C; Chase David J; Schlievert Patrick M
Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons.
Schlievert Patrick M
Cytolysins, superantigens, and pneumonia due to community-associated methicillin-resistant Staphylococcus aureus.
Li Qingsheng; Estes Jacob D; Schlievert Patrick M; Duan Lijie; Brosnahan Amanda J; Southern Peter J; Reilly Cavan S; Peterson Marnie L; Schultz-Darken Nancy; Brunner Kevin G; Nephew Karla R; Pambuccian Stefan; Lifson Jeffrey D; Carlis John V; Haase Ashley T
Glycerol monolaurate prevents mucosal SIV transmission.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Patrick Schlievert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Strandberg Kristi L; Peterson Marnie L; Schaefers Matthew M; Case Laura C; Pack Melinda C; Chase David J; Schlievert Patrick M
Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(11):1711-7.
2009: Schlievert Patrick M
Cytolysins, superantigens, and pneumonia due to community-associated methicillin-resistant Staphylococcus aureus.
The Journal of infectious diseases 2009;200(5):676-8.
2009: Li Qingsheng; Estes Jacob D; Schlievert Patrick M; Duan Lijie; Brosnahan Amanda J; Southern Peter J; Reilly Cavan S; Peterson Marnie L; Schultz-Darken Nancy; Brunner Kevin G; Nephew Karla R; Pambuccian Stefan; Lifson Jeffrey D; Carlis John V; Haase Ashley T
Glycerol monolaurate prevents mucosal SIV transmission.
Nature 2009;458(7241):1034-8.
2009: Assimacopoulos Aristides P; Strandberg Kristi L; Rotschafer Jessica H; Schlievert Patrick M
Extreme pyrexia and rapid death due to Staphylococcus aureus infection: analysis of 2 cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(5):612-4.
2009: Brosnahan Amanda J; Mantz Mary J; Squier Christopher A; Peterson Marnie L; Schlievert Patrick M
Cytolysins augment superantigen penetration of stratified mucosa.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(4):2364-73.
2009: Lin Ying-Chi; Schlievert Patrick M; Anderson Michele J; Fair Christina L; Schaefers Matthew M; Muthyala Ramaiah; Peterson Marnie L
Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo.
PloS one 2009;4(10):e7499.
2008: Brosnahan Amanda J; Schaefers Matthew M; Amundson William H; Mantz Mary J; Squier Christopher A; Peterson Marnie L; Schlievert Patrick M
Novel toxic shock syndrome toxin-1 amino acids required for biological activity.
Biochemistry 2008;47(49):12995-3003.
2008: Schlievert Patrick M; Strandberg Kristi L; Brosnahan Amanda J; Peterson Marnie L; Pambuccian Stefan E; Nephew Karla R; Brunner Kevin G; Schultz-Darken Nancy J; Haase Ashley T
Glycerol monolaurate does not alter rhesus macaque (Macaca mulatta) vaginal lactobacilli and is safe for chronic use.
Antimicrobial agents and chemotherapy 2008;52(12):4448-54.
2008: Yang Xi; Buonpane Rebecca A; Moza Beenu; Rahman A K M Nur-ur; Wang Ningyan; Schlievert Patrick M; McCormick John K; Sundberg Eric J; Kranz David M
Neutralization of multiple staphylococcal superantigens by a single-chain protein consisting of affinity-matured, variable domain repeats.
The Journal of infectious diseases 2008;198(3):344-8.
2008: Weivoda Starchild; Andersen John D; Skogen Aunica; Schlievert Patrick M; Fontana Donna; Schacker Timothy; Tuite Paul; Dubinsky Janet M; Jemmerson Ronald
ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand.
Journal of immunological methods 2008;336(1):22-9.
2008: Schlievert Patrick M; Case Laura C; Strandberg Kristi L; Abrams Bea B; Leung Donald Y M
Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(10):1562-7.
2008: Squier Christopher A; Mantz Mary J; Schlievert Patrick M; Davis Catherine C
Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa.
Journal of pharmaceutical sciences 2008;97(1):9-21.
2007: Schlievert Patrick M; Case Laura C; Nemeth Kimberly A; Davis Catherine C; Sun Yiping; Qin Wendy; Wang Fancheng; Brosnahan Amanda J; Mleziva John A; Peterson Marnie L; Jones Bruce E
Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins.
Biochemistry 2007;46(50):14349-58.
2007: Huseby Medora; Shi Ke; Brown C Kent; Digre Jeff; Mengistu Fikre; Seo Keun Seok; Bohach Gregory A; Schlievert Patrick M; Ohlendorf Douglas H; Earhart Cathleen A
Structure and biological activities of beta toxin from Staphylococcus aureus.
Journal of bacteriology 2007;189(23):8719-26.
2007: Pragman Alexa A; Herron-Olson Lisa; Case Laura C; Vetter Sara M; Henke Evan E; Kapur Vivek; Schlievert Patrick M
Sequence analysis of the Staphylococcus aureus srrAB loci reveals that truncation of srrA affects growth and virulence factor expression.
Journal of bacteriology 2007;189(20):7515-9.
2007: Ulrich Martina; Bastian Mike; Cramton Sarah E; Ziegler Katrin; Pragman Alexa A; Bragonzi Alessandra; Memmi Guido; Wolz Christiane; Schlievert Patrick M; Cheung Ambrose; Döring Gerd
The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions.
Molecular microbiology 2007;65(5):1276-87.
2007: Schlievert Patrick M
Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.
Antimicrobial agents and chemotherapy 2007;51(9):3056-62.
2007: Schlievert Patrick M; Case Laura C; Strandberg Kristi L; Tripp Timothy J; Lin Ying-Chi; Peterson Marnie L
Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005.
Journal of clinical microbiology 2007;45(8):2704-7.
2007: Vetter Sara M; Schlievert Patrick M
The two-component system Bacillus respiratory response A and B (BrrA-BrrB) is a virulence factor regulator in Bacillus anthracis.
Biochemistry 2007;46(25):7343-52.
2007: Kotler Donald P; Sandkovsky Uriel; Schlievert Patrick M; Sordillo Emilia Mia
Toxic shock-like syndrome associated with staphylococcal enterocolitis in an HIV-infected man.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(12):e121-3.
2007: Buonpane Rebecca A; Churchill Hywyn R O; Moza Beenu; Sundberg Eric J; Peterson Marnie L; Schlievert Patrick M; Kranz David M
Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists.
Nature medicine 2007;13(6):725-9.
2007: Brouillard Jean-Nicholas P; Günther Sebastian; Varma Ashok K; Gryski Irene; Herfst Christine A; Rahman A K M Nur-ur; Leung Donald Y M; Schlievert Patrick M; Madrenas Joaquín; Sundberg Eric J; McCormick John K
Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens.
Journal of molecular biology 2007;367(4):925-34.
2007: Pragman Alexa A; Ji Yinduo; Schlievert Patrick M
Repression of Staphylococcus aureus SrrAB using inducible antisense srrA alters growth and virulence factor transcript levels.
Biochemistry 2007;46(1):314-21.
2007: Schlievert Patrick M; Case Laura C
Molecular analysis of staphylococcal superantigens.
Methods in molecular biology (Clifton, N.J.) 2007;391():113-26.
2006: Phillips James R; Tripp Timothy J; Regelmann Warren E; Schlievert Patrick M; Wangensteen O Douglas
Staphylococcal alpha-toxin causes increased tracheal epithelial permeability.
Pediatric pulmonology 2006;41(12):1146-52.
2006: Peterson Marnie L; Schlievert Patrick M
Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells.
Biochemistry 2006;45(7):2387-97.
2006: Cone Lawrence A; Stone Richard A; Schlievert Patrick M; Sneider Ronald A; Rubin Andrew M; Jesser Kenneth; Renker Stacey W
An early favorable outcome of streptococcal toxic shock syndrome may require a combination of antimicrobial and intravenous gamma globulin therapy together with activated protein C.
Scandinavian journal of infectious diseases 2006;38(11-12):960-3.
2005: Hill Donna R; Brunner Marianne E; Schmitz Deborah C; Davis Catherine C; Flood Janine A; Schlievert Patrick M; Wang-Weigand Sherry Z; Osborn Thomas W
In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses.
Journal of applied physiology (Bethesda, Md. : 1985) 2005;99(4):1582-91.
2005: Schlievert Patrick M
Staphylococcal toxic shock syndrome: still a problem.
The Medical journal of Australia 2005;182(12):651-2.
2005: Kravitz Gary R; Dries David J; Peterson Marnie L; Schlievert Patrick M
Purpura fulminans due to Staphylococcus aureus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(7):941-7.
2005: Vetter Sara M; Schlievert Patrick M
Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis.
Antimicrobial agents and chemotherapy 2005;49(4):1302-5.
2005: Peterson Marnie L; Ault Kevin; Kremer Mary J; Klingelhutz Aloysius J; Davis Catherine C; Squier Christopher A; Schlievert Patrick M
The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1.
Infection and immunity 2005;73(4):2164-74.
2004: Perkins Stephen L; Han Dennis P; Burke Janice M; Schlievert Patrick M; Wirostko William J; Tarasewicz Dariusz G; Skumatz Christine M B
Intravitreally injected human immunoglobulin attenuates the effects of Staphylococcus aureus culture supernatant in a rabbit model of toxin-mediated endophthalmitis.
Archives of ophthalmology 2004;122(10):1499-506.
2004: Pragman Alexa A; Schlievert Patrick M
Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation.
FEMS immunology and medical microbiology 2004;42(2):147-54.
2004: Schlievert Patrick M; Tripp Timothy J; Peterson Marnie L
Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.
Journal of clinical microbiology 2004;42(6):2875-6.
2004: Waters Christopher M; Hirt Helmut; McCormick John K; Schlievert Patrick M; Wells Carol L; Dunny G M
An amino-terminal domain of Enterococcus faecalis aggregation substance is required for aggregation, bacterial internalization by epithelial cells and binding to lipoteichoic acid.
Molecular microbiology 2004;52(4):1159-71.
2004: Flood J A; Tripp T J; Davis C C; Hill D R; Schlievert P M
A toroid model for in vitro investigations of toxic shock syndrome toxin-1 production.
Journal of microbiological methods 2004;57(2):283-8.
2004: Pragman Alexa A; Yarwood Jeremy M; Tripp Timothy J; Schlievert Patrick M
Characterization of virulence factor regulation by SrrAB, a two-component system in Staphylococcus aureus.
Journal of bacteriology 2004;186(8):2430-8.
2004: Dahl Mark V; Ross Amy J; Schlievert Patrick M
Temperature regulates bacterial protein production: possible role in rosacea.
Journal of the American Academy of Dermatology 2004;50(2):266-72.
2004: Kim Suck Won; Grant Jon E; Kim Sandra I; Swanson Todd A; Bernstein Gail A; Jaszcz Waclaw B; Williams Kyle A; Schlievert Patrick M
A possible association of recurrent streptococcal infections and acute onset of obsessive-compulsive disorder.
The Journal of neuropsychiatry and clinical neurosciences 2004;16(3):252-60.
2003: Davis Catherine C; Kremer Mary J; Schlievert Patrick M; Squier Christopher A
Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage.
American journal of obstetrics and gynecology 2003;189(6):1785-91.
2003: Yarwood Jeremy M; Schlievert Patrick M
Quorum sensing in Staphylococcus infections.
The Journal of clinical investigation 2003;112(11):1620-5.
2003: Bernstein Joel M; Ballow Mark; Schlievert Patrick M; Rich Gary; Allen Cheryl; Dryja Diane
A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis.
American journal of rhinology 2003;17(6):321-6.
2003: Saiman Lisa; O'Keefe Mary; Graham Philip L; Wu Fann; Saïd-Salim Battouli; Kreiswirth Barry; LaSala Anita; Schlievert Patrick M; Della-Latta Phyllis
Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(10):1313-9.
2003: Dinges Martin M; Gregerson Dale S; Tripp Timothy J; McCormick John K; Schlievert Patrick M
Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.
The Journal of infectious diseases 2003;188(8):1142-5.
2003: Sundberg Eric J; Andersen Peter S; Schlievert Patrick M; Karjalainen Klaus; Mariuzza Roy A
Structural, energetic, and functional analysis of a protein-protein interface at distinct stages of affinity maturation.
Structure (London, England : 1993) 2003;11(9):1151-61.
2003: McCormick John K; Tripp Timothy J; Llera Andrea S; Sundberg Eric J; Dinges Martin M; Mariuzza Roy A; Schlievert Patrick M
Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(3):1385-92.
2003: Orwin Paul M; Fitzgerald J Ross; Leung Donald Y M; Gutierrez Juan A; Bohach Gregory A; Schlievert Patrick M
Characterization of Staphylococcus aureus enterotoxin L.
Infection and immunity 2003;71(5):2916-9.
2003: Fitzgerald J Ross; Reid Sean D; Ruotsalainen Eeva; Tripp Timothy J; Liu MengYao; Cole Robert; Kuusela Pentti; Schlievert Patrick M; Järvinen Asko; Musser James M
Genome diversification in Staphylococcus aureus: Molecular evolution of a highly variable chromosomal region encoding the Staphylococcal exotoxin-like family of proteins.
Infection and immunity 2003;71(5):2827-38.
2003: Holbrook Todd C; Munday John S; Brown Cathy A; Glover Betty; Schlievert Patrick M; Sanchez Susan
Toxic shock syndrome in a horse with Staphylococcus aureus pneumonia.
Journal of the American Veterinary Medical Association 2003;222(5):620-3, 601-2.
2003: Tripp Timothy J; McCormick John K; Webb Jennifer M; Schlievert Patrick M
The zinc-dependent major histocompatibility complex class II binding site of streptococcal pyrogenic exotoxin C is critical for maximal superantigen function and toxic activity.
Infection and immunity 2003;71(3):1548-50.
2003: Fey P D; Saïd-Salim B; Rupp M E; Hinrichs S H; Boxrud D J; Davis C C; Kreiswirth B N; Schlievert P M
Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2003;47(1):196-203.
2003: McCormick John K; Bohach Gregory A; Schlievert Patrick M
Pyrogenic, lethal, and emetic properties of superantigens in rabbits and primates.
Methods in molecular biology (Clifton, N.J.) 2003;214():245-53.
2003: McCormick John K; Schlievert Patrick M
Expression, purification, and detection of novel streptococcal superantigens.
Methods in molecular biology (Clifton, N.J.) 2003;214():33-43.
2002: Smoot Laura M; McCormick John K; Smoot James C; Hoe Nancy P; Strickland Ian; Cole Robert L; Barbian Kent D; Earhart Cathleen A; Ohlendorf Douglas H; Veasy L George; Hill Harry R; Leung Donald Y M; Schlievert Patrick M; Musser James M
Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks.
Infection and immunity 2002;70(12):7095-104.
2002: Orwin Paul M; Leung Donald Y M; Tripp Timothy J; Bohach Gregory A; Earhart Cathleen A; Ohlendorf Douglas H; Schlievert Patrick M
Characterization of a novel staphylococcal enterotoxin-like superantigen, a member of the group V subfamily of pyrogenic toxins.
Biochemistry 2002;41(47):14033-40.
2002: Beres Stephen B; Sylva Gail L; Barbian Kent D; Lei Benfang; Hoff Jessica S; Mammarella Nicole D; Liu Meng-Yao; Smoot James C; Porcella Stephen F; Parkins Larye D; Campbell David S; Smith Todd M; McCormick John K; Leung Donald Y M; Schlievert Patrick M; Musser James M
Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(15):10078-83.
2002: Leung Donald Y M; Meissner H Cody; Shulman Stanford T; Mason Wilbert H; Gerber Michael A; Glode Mary P; Myones Barry L; Wheeler J Gary; Ruthazer Robin; Schlievert Patrick M
Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.
The Journal of pediatrics 2002;140(6):742-6.
2002: Sundberg Eric J; Li Hongmin; Llera Andrea S; McCormick John K; Tormo José; Schlievert Patrick M; Karjalainen Klaus; Mariuzza Roy A
Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes.
Structure (London, England : 1993) 2002;10(5):687-99.
2002: McCormick John K; Tripp Timothy J; Dunny Gary M; Schlievert Patrick M
Formation of vegetations during infective endocarditis excludes binding of bacterial-specific host antibodies to Enterococcus faecalis.
The Journal of infectious diseases 2002;185(7):994-7.
2002: Yarwood Jeremy M; McCormick John K; Paustian Michael L; Orwin Paul M; Kapur Vivek; Schlievert Patrick M
Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands.
The Journal of biological chemistry 2002;277(15):13138-47.
2002: Yarwood Jeremy M; McCormick John K; Paustian Michael L; Kapur Vivek; Schlievert Patrick M
Repression of the Staphylococcus aureus accessory gene regulator in serum and in vivo.
Journal of bacteriology 2002;184(4):1095-101.
2002: Hirt Helmut; Schlievert Patrick M; Dunny Gary M
In vivo induction of virulence and antibiotic resistance transfer in Enterococcus faecalis mediated by the sex pheromone-sensing system of pCF10.
Infection and immunity 2002;70(2):716-23.
2002: Cone Lawrence A; Byrd Richard G; Schulz Karl; Schlievert Patrick M
Recurrent nonmenstrual toxic shock.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(2):289.
2001: Dinges M M; Schlievert P M
Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1.
Infection and immunity 2001;69(11):7169-72.
2001: Schlievert P M
Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses.
The Journal of allergy and clinical immunology 2001;108(4 Suppl):S107-10.
2001: McCormick J K; Hirt H; Waters C M; Tripp T J; Dunny G M; Schlievert P M
Antibodies to a surface-exposed, N-terminal domain of aggregation substance are not protective in the rabbit model of Enterococcus faecalis infective endocarditis.
Infection and immunity 2001;69(5):3305-14.
2001: Reed S B; Wesson C A; Liou L E; Trumble W R; Schlievert P M; Bohach G A; Bayles K W
Molecular characterization of a novel Staphylococcus aureus serine protease operon.
Infection and immunity 2001;69(3):1521-7.
2001: McCormick J K; Pragman A A; Stolpa J C; Leung D Y; Schlievert P M
Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen.
Infection and immunity 2001;69(3):1381-8.
2001: Dinges M M; Schlievert P M
Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice.
Infection and immunity 2001;69(3):1256-64.
2001: Yarwood J M; McCormick J K; Schlievert P M
Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus.
Journal of bacteriology 2001;183(4):1113-23.
2001: Li Y; Li H; Dimasi N; McCormick J K; Martin R; Schuck P; Schlievert P M; Mariuzza R A
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II.
Immunity 2001;14(1):93-104.
2001: Orwin P M; Leung D Y; Donahue H L; Novick R P; Schlievert P M
Biochemical and biological properties of Staphylococcal enterotoxin K.
Infection and immunity 2001;69(1):360-6.
2001: McCormick J K; Yarwood J M; Schlievert P M
Toxic shock syndrome and bacterial superantigens: an update.
Annual review of microbiology 2001;55():77-104.
2000: Mitchell D T; Levitt D G; Schlievert P M; Ohlendorf D H
Structural evidence for the evolution of pyrogenic toxin superantigens.
Journal of molecular evolution 2000;51(6):520-31.
2000: Yarwood J M; Leung D Y; Schlievert P M
Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome.
FEMS microbiology letters 2000;192(1):1-7.
2000: Earhart C A; Vath G M; Roggiani M; Schlievert P M; Ohlendorf D H
Structure of streptococcal pyrogenic exotoxin A reveals a novel metal cluster.
Protein science : a publication of the Protein Society 2000;9(9):1847-51.
2000: Roggiani M; Stoehr J A; Olmsted S B; Matsuka Y V; Pillai S; Ohlendorf D H; Schlievert P M
Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome.
Infection and immunity 2000;68(9):5011-7.
2000: McCormick J K; Tripp T J; Olmsted S B; Matsuka Y V; Gahr P J; Ohlendorf D H; Schlievert P M
Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(4):2306-12.
2000: Schlievert P M; Jablonski L M; Roggiani M; Sadler I; Callantine S; Mitchell D T; Ohlendorf D H; Bohach G A
Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals.
Infection and immunity 2000;68(6):3630-4.
2000: Yarwood J M; Schlievert P M
Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8.
Journal of clinical microbiology 2000;38(5):1797-803.
2000: Rago J V; Vath G M; Tripp T J; Bohach G A; Ohlendorf D H; Schlievert P M
Staphylococcal exfoliative toxins cleave alpha- and beta-melanocyte-stimulating hormones.
Infection and immunity 2000;68(4):2366-8.
2000: Rago J V; Vath G M; Bohach G A; Ohlendorf D H; Schlievert P M
Mutational analysis of the superantigen staphylococcal exfoliative toxin A (ETA).
Journal of immunology (Baltimore, Md. : 1950) 2000;164(4):2207-13.
2000: Dinges M M; Orwin P M; Schlievert P M
Exotoxins of Staphylococcus aureus.
Clinical microbiology reviews 2000;13(1):16-34, table of contents.
1999: Wann E R; Fehringer A P; Ezepchuk Y V; Schlievert P M; Bina P; Reiser R F; Höök M M; Leung D Y
Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A.
Infection and immunity 1999;67(9):4737-43.
1999: Vath G M; Earhart C A; Monie D D; Iandolo J J; Schlievert P M; Ohlendorf D H
The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity.
Biochemistry 1999;38(32):10239-46.
1999: Andersen P S; Lavoie P M; Sékaly R P; Churchill H; Kranz D M; Schlievert P M; Karjalainen K; Mariuzza R A
Role of the T cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes.
Immunity 1999;10(4):473-83.
1999: Monday S R; Vath G M; Ferens W A; Deobald C; Rago J V; Gahr P J; Monie D D; Iandolo J J; Chapes S K; Davis W C; Ohlendorf D H; Schlievert P M; Bohach G A
Unique superantigen activity of staphylococcal exfoliative toxins.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(8):4550-9.
1999: Hofer M F; Harbeck R J; Schlievert P M; Leung D Y
Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen.
The Journal of investigative dermatology 1999;112(2):171-6.
1998: Li H; Llera A; Tsuchiya D; Leder L; Ysern X; Schlievert P M; Karjalainen K; Mariuzza R A
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B.
Immunity 1998;9(6):807-16.
1998: Earhart C A; Mitchell D T; Murray D L; Pinheiro D M; Matsumura M; Schlievert P M; Ohlendorf D H
Structures of five mutants of toxic shock syndrome toxin-1 with reduced biological activity.
Biochemistry 1998;37(20):7194-202.
1998: Saiman L; Jakob K; Holmes K W; Whittier S; Garzon M C; Rago J V; Schlievert P M; Della-Latta P
Molecular epidemiology of staphylococcal scalded skin syndrome in premature infants.
The Pediatric infectious disease journal 1998;17(4):329-34.
1998: Leder L; Llera A; Lavoie P M; Lebedeva M I; Li H; Sékaly R P; Bohach G A; Gahr P J; Schlievert P M; Karjalainen K; Mariuzza R A
A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II.
The Journal of experimental medicine 1998;187(6):823-33.
1998: Schlievert P M; Gahr P J; Assimacopoulos A P; Dinges M M; Stoehr J A; Harmala J W; Hirt H; Dunny G M
Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis.
Infection and immunity 1998;66(1):218-23.
1998: Rago J V; Schlievert P M
Mechanisms of pathogenesis of staphylococcal and streptococcal superantigens.
Current topics in microbiology and immunology 1998;225():81-97.
1997: Leung D Y; Sullivan K E; Brown-Whitehorn T F; Fehringer A P; Allen S; Finkel T H; Washington R L; Makida R; Schlievert P M
Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.
Pediatric research 1997;42(3):268-72.
1997: Roggiani M; Stoehr J A; Leonard B A; Schlievert P M
Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants.
Infection and immunity 1997;65(7):2868-75.
1997: Prasad G S; Radhakrishnan R; Mitchell D T; Earhart C A; Dinges M M; Cook W J; Schlievert P M; Ohlendorf D H
Refined structures of three crystal forms of toxic shock syndrome toxin-1 and of a tetramutant with reduced activity.
Protein science : a publication of the Protein Society 1997;6(6):1220-7.
1997: Gaskin D K; Bohach G A; Schlievert P M; Hovde C J
Purification of Staphylococcus aureus beta-toxin: comparison of three isoelectric focusing methods.
Protein expression and purification 1997;9(1):76-82.
1997: Vath G M; Earhart C A; Rago J V; Kim M H; Bohach G A; Schlievert P M; Ohlendorf D H
The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease.
Biochemistry 1997;36(7):1559-66.
1997: Schlievert P M; Dunny G M; Stoehr J A; Assimacopoulos A P
Aggregation and binding substances enhance pathogenicity in a rabbit model of Enterococcus faecalis endocarditis.
Advances in experimental medicine and biology 1997;418():789-91.
1997: Assimacopoulos A P; Stoehr J A; Schlievert P M
Mitogenic factors from group G streptococci associated with scarlet fever and streptococcal toxic shock syndrome.
Advances in experimental medicine and biology 1997;418():109-14.
1996: Wagner J G; Schlievert P M; Assimacopoulos A P; Stoehr J A; Carson P J; Komadina K
Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(5):1159-61.
1996: Fields B A; Malchiodi E L; Li H; Ysern X; Stauffacher C V; Schlievert P M; Karjalainen K; Mariuzza R A
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen.
Nature 1996;384(6605):188-92.
1996: Schlievert P M
Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins.
Journal of the American College of Surgeons 1996;183(1):19-24.
1996: Hofer M F; Newell K; Duke R C; Schlievert P M; Freed J H; Leung D Y
Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(11):5425-30.
1996: Witcher K J; Novick R P; Schlievert P M
Modulation of immune cell proliferation by glycerol monolaurate.
Clinical and diagnostic laboratory immunology 1996;3(1):10-3.
1996: Schlievert P M; Assimacopoulos A P; Cleary P P
Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis.
The Journal of laboratory and clinical medicine 1996;127(1):13-22.
1996: Murray D L; Earhart C A; Mitchell D T; Ohlendorf D H; Novick R P; Schlievert P M
Localization of biologically important regions on toxic shock syndrome toxin 1.
Infection and immunity 1996;64(1):371-4.
1996: Bohach G A; Stauffacher C V; Ohlendorf D H; Chi Y I; Vath G M; Schlievert P M
The staphylococcal and streptococcal pyrogenic toxin family.
Advances in experimental medicine and biology 1996;391():131-54.
1995: Hofer M F; Lester M R; Schlievert P M; Leung D Y
Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1995;25(12):1218-27.
1995: Malchiodi E L; Eisenstein E; Fields B A; Ohlendorf D H; Schlievert P M; Karjalainen K; Mariuzza R A
Superantigen binding to a T cell receptor beta chain of known three-dimensional structure.
The Journal of experimental medicine 1995;182(6):1833-45.
1995: Schlievert P M; Bohach G A; Ohlendorf D H; Stauffacher C V; Leung D Y; Murray D L; Prasad G S; Earhart C A; Jablonski L M; Hoffmann M L; Chi Y I
Molecular structure of staphylococcus and streptococcus superantigens.
Journal of clinical immunology 1995;15(6 Suppl):4S-10S.
1995: Schlievert P M
Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin.
The Journal of infectious diseases 1995;172(4):1112-4.
1994: Murray D L; Prasad G S; Earhart C A; Leonard B A; Kreiswirth B N; Novick R P; Ohlendorf D H; Schlievert P M
Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(1):87-95.
1993: Prasad G S; Earhart C A; Murray D L; Novick R P; Schlievert P M; Ohlendorf D H
Structure of toxic shock syndrome toxin 1.
Biochemistry 1993;32(50):13761-6.
1993: Earhart C A; Prasad G S; Murray D L; Novick R P; Schlievert P M; Ohlendorf D H
Growth and analysis of crystal forms of toxic shock syndrome toxin 1.
Proteins 1993;17(3):329-34.
1993: Schlievert P M; Gocke J E; Deringer J R
Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(1):26-31.
1992: Leonard B A; Schlievert P M
Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin.
Infection and immunity 1992;60(9):3747-55.
1992: Lee P K; Kreiswirth B N; Deringer J R; Projan S J; Eisner W; Smith B L; Carlson E; Novick R P; Schlievert P M
Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus.
The Journal of infectious diseases 1992;165(6):1056-63.
1992: Schlievert P M; Deringer J R; Kim M H; Projan S J; Novick R P
Effect of glycerol monolaurate on bacterial growth and toxin production.
Antimicrobial agents and chemotherapy 1992;36(3):626-31.
1991: Lee P K; Vercellotti G M; Deringer J R; Schlievert P M
Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells.
The Journal of infectious diseases 1991;164(4):711-9.
1991: Hauser A R; Stevens D L; Kaplan E L; Schlievert P M
Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome.
Journal of clinical microbiology 1991;29(8):1562-7.
1991: Lee P K; Deringer J R; Kreiswirth B N; Novick R P; Schlievert P M
Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.
Infection and immunity 1991;59(3):879-84.
1991: Leonard B A; Lee P K; Jenkins M K; Schlievert P M
Cell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity.
Infection and immunity 1991;59(3):1210-4.
1991: Lee P K; Schlievert P M
Molecular genetics of pyrogenic exotoxin "superantigens" of group A streptococci and Staphylococcus aureus.
Current topics in microbiology and immunology 1991;174():1-19.
1990: Hauser A R; Schlievert P M
Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor.
Journal of bacteriology 1990;172(8):4536-42.
1990: McCollister B D; Kreiswirth B N; Novick R P; Schlievert P M
Production of toxic shock syndrome-like illness in rabbits by Staphylococcus aureus D4508: association with enterotoxin A.
Infection and immunity 1990;58(7):2067-70.
1990: Norton S D; Schlievert P M; Novick R P; Jenkins M K
Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(6):2089-95.
1990: Bohach G A; Fast D J; Nelson R D; Schlievert P M
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
Critical reviews in microbiology 1990;17(4):251-72.
1989: Lee P K; Schlievert P M
Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness.
Journal of clinical microbiology 1989;27(8):1890-2.
1989: Bohach G A; Schlievert P M
Conservation of the biologically active portions of staphylococcal enterotoxins C1 and C2.
Infection and immunity 1989;57(7):2249-52.
1989: Goshorn S C; Schlievert P M
Bacteriophage association of streptococcal pyrogenic exotoxin type C.
Journal of bacteriology 1989;171(6):3068-73.
1989: Schlievert P M; Gray E D
Group A streptococcal pyrogenic exotoxin (scarlet fever toxin) type A and blastogen A are the same protein.
Infection and immunity 1989;57(6):1865-7.
1989: Bohach G A; Handley J P; Schlievert P M
Biological and immunological properties of the carboxyl terminus of staphylococcal enterotoxin C1.
Infection and immunity 1989;57(1):23-8.
1989: Schlievert P M
Role of toxic shock syndrome toxin 1 in toxic shock syndrome: overview.
Reviews of infectious diseases 1989;11 Suppl 1():S107-9.
1989: Fast D J; Schlievert P M; Nelson R D
Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production.
Infection and immunity 1989;57(1):291-4.
1989: Bohach G A; Kreiswirth B N; Novick R P; Schlievert P M
Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins B and C1 with use of southern hybridization and immunologic assays.
Reviews of infectious diseases 1989;11 Suppl 1():S75-81; discussion S81-2.
1988: Goshorn S C; Schlievert P M
Nucleotide sequence of streptococcal pyrogenic exotoxin type C.
Infection and immunity 1988;56(9):2518-20.
1988: Murphy B G; Kreiswirth B N; Novick R P; Schlievert P M
Localization of a biologically important epitope on toxic-shock-syndrome toxin-1.
The Journal of infectious diseases 1988;158(3):549-55.
1988: Bohach G A; Hauser A R; Schlievert P M
Cloning of the gene, speB, for streptococcal pyrogenic exotoxin type B in Escherichia coli.
Infection and immunity 1988;56(6):1665-7.
1988: Fast D J; Schlievert P M; Nelson R D
Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(3):949-53.
1988: Bohach G A; Hovde C J; Handley J P; Schlievert P M
Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies.
Infection and immunity 1988;56(2):400-4.

Sign-in to see more